Johnson Johnson expects global sales of $2.5 billion from coronavirus vaccines in 2021

(Natural News) Johnson & Johnson expects to make $2.5 billion in global sales for 2021 from its single-dose Wuhan coronavirus (COVID-19) vaccine. The American firm’s July 21 remarks come following the release of its second-quarter earnings for the year – with favorable numbers. The projection follows concerns over its vaccine’s effectiveness against more infectious coronavirus strains. The company...